The LORD trial: A randomized, non- inferiority trial, between active surveillance versus standard treatment in patients with low risk ductal carcinoma in situ

Lotte E. Elshof; Konstantinos Tryfonidis; Leen Slaets; A. Elise van Leeuwen-Stok; Nicolas Dif; Victoria P. Skinner; Claudette E. Loo; Gonneke Warnars; Eveline Bleiker; Ruud M. Pijnappel; Nina Bijker; Emiel Jth Rutgers; Jelle Wesseling

doi:10.1158/1538-7445.SABCS14-OT3-6-01

The LORD trial: A randomized, non- inferiority trial, between active surveillance versus standard treatment in patients with low risk ductal carcinoma in situ

Lotte E. Elshof, Konstantinos Tryfonidis, Leen Slaets, A. Elise van Leeuwen-Stok, Nicolas Dif, Victoria P. Skinner, Claudette E. Loo, Gonneke Warnars, Eveline Bleiker, Ruud M. Pijnappel, Nina Bijker, Emiel Jth Rutgers, Jelle Wesseling

Research output: Contribution to journal › Meeting Abstract › Other research output

Original language	English
Number of pages	2
Journal	Cancer Research
Volume	75
Issue number	9
DOIs	https://doi.org/10.1158/1538-7445.SABCS14-OT3-6-01
Publication status	Published - 1 May 2015
Event	37th Annual CTRC-AACR San Antonio Breast Cancer Symposium - San Antonio, Netherlands Duration: 9 Dec 2014 → 13 Dec 2014

Access to Document

10.1158/1538-7445.SABCS14-OT3-6-01

Cite this

Elshof, L. E., Tryfonidis, K., Slaets, L., van Leeuwen-Stok, A. E., Dif, N., Skinner, V. P., Loo, C. E., Warnars, G., Bleiker, E., Pijnappel, R. M., Bijker, N., Rutgers, E. J., & Wesseling, J. (2015). The LORD trial: A randomized, non- inferiority trial, between active surveillance versus standard treatment in patients with low risk ductal carcinoma in situ. Cancer Research, 75(9). https://doi.org/10.1158/1538-7445.SABCS14-OT3-6-01

@article{c3efce947bf346e9b3c4451a0f63d273,

title = "The LORD trial: A randomized, non- inferiority trial, between active surveillance versus standard treatment in patients with low risk ductal carcinoma in situ",

author = "Elshof, {Lotte E.} and Konstantinos Tryfonidis and Leen Slaets and {van Leeuwen-Stok}, {A. Elise} and Nicolas Dif and Skinner, {Victoria P.} and Loo, {Claudette E.} and Gonneke Warnars and Eveline Bleiker and Pijnappel, {Ruud M.} and Nina Bijker and Rutgers, {Emiel Jth} and Jelle Wesseling",

year = "2015",

month = may,

day = "1",

doi = "10.1158/1538-7445.SABCS14-OT3-6-01",

language = "English",

volume = "75",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

number = "9",

note = "37th Annual CTRC-AACR San Antonio Breast Cancer Symposium ; Conference date: 09-12-2014 Through 13-12-2014",

}

Elshof, LE, Tryfonidis, K, Slaets, L, van Leeuwen-Stok, AE, Dif, N, Skinner, VP, Loo, CE, Warnars, G, Bleiker, E, Pijnappel, RM, Bijker, N, Rutgers, EJ & Wesseling, J 2015, 'The LORD trial: A randomized, non- inferiority trial, between active surveillance versus standard treatment in patients with low risk ductal carcinoma in situ', Cancer Research, vol. 75, no. 9. https://doi.org/10.1158/1538-7445.SABCS14-OT3-6-01

TY - JOUR

T1 - The LORD trial

T2 - 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium

AU - Elshof, Lotte E.

AU - Tryfonidis, Konstantinos

AU - Slaets, Leen

AU - van Leeuwen-Stok, A. Elise

AU - Dif, Nicolas

AU - Skinner, Victoria P.

AU - Loo, Claudette E.

AU - Warnars, Gonneke

AU - Bleiker, Eveline

AU - Pijnappel, Ruud M.

AU - Bijker, Nina

AU - Rutgers, Emiel Jth

AU - Wesseling, Jelle

PY - 2015/5/1

Y1 - 2015/5/1

U2 - 10.1158/1538-7445.SABCS14-OT3-6-01

DO - 10.1158/1538-7445.SABCS14-OT3-6-01

M3 - Meeting Abstract

SN - 0008-5472

VL - 75

JO - Cancer Research

JF - Cancer Research

IS - 9

Y2 - 9 December 2014 through 13 December 2014

ER -